EU regulator backs Lilly’s Alzheimer’s drug – POLITICO

The European Medicines Agency has granted restricted EU authorization to Eli Lilly’s Alzheimer’s drug Kisunla, reversing an earlier decision to reject the drug over concerns that its benefits don’t…